Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Pain Therapeutics (PTIE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 51,414
  • Shares Outstanding, K 6,600
  • Annual Sales, $ 0 K
  • Annual Income, $ -14,850 K
  • 36-Month Beta 2.11
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 4.52

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.79 +105.54%
on 12/29/17
12.80 -39.14%
on 01/09/18
+3.58 (+85.04%)
since 12/19/17
3-Month
3.10 +151.29%
on 10/30/17
12.80 -39.14%
on 01/09/18
+3.73 (+91.87%)
since 10/19/17
52-Week
3.10 +151.29%
on 10/30/17
12.80 -39.14%
on 01/09/18
+3.87 (+98.72%)
since 01/19/17

Most Recent Stories

More News
FDA Clearance & Billion Dollar Markets Could Make Biotricity (BTCY) a Better Buy than Bitcoin in 2018

- Biotricity's (BTCY) new medical device Bioflux now USFDA cleared and ready for commercial launch. Company has key components in place for successful sales effort, including financing and probable insurance...

PTIE : 7.79 (unch)
NVAX : 1.97 (+8.24%)
Orphan Rare Diseases R&D Advancements Increase Novel Therapeutic Options for Drug Development Pipeline

Rare conditions are also known as Orphan diseases which are generally categorized as chronic, degenerative and life-threatening in nature and normally include certain cancers, metabolic conditions, diseases...

PTIE : 7.79 (unch)
DFFN : 0.71 (unch)
GBT : 53.95 (+1.79%)
TEVA : 20.70 (-0.05%)
MBRX : 1.85 (+0.54%)
Pain Therapeutics, REMOXY Gets Positive Study Results, Updates for FENROCK and PTI-125

NEW YORK, NY / ACCESSWIRE / January 10, 2018 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies, is issuing a comprehensive...

PTIE : 7.79 (unch)
Today's Research Reports on Stocks to Watch: Diffusion Pharmaceuticals and Pain Therapeutics

NEW YORK, NY / ACCESSWIRE / January 10, 2018 / Diffusion Pharmaceuticals and Pain Therapeutics were two biotech stocks scorching on Tuesday. Shares of Pain Therapeutics even hit a new high after announcing...

DFFN : 0.71 (unch)
PTIE : 7.79 (unch)
2 Biotech Stocks Climbing on Positive Findings

CORAL GABLES, FL / ACCESSWIRE / January 9, 2018 / The biotech industry continues to be a good sector for investments. This has been based on traders' expectations that the number of mergers and acquisitions,...

PTIE : 7.79 (unch)
GTBP : 4.2000 (-1.18%)
Osteoarthritis Pain Therapeutics Pipeline Review, H2 2017 - Research and Markets

The "Osteoarthritis Pain - Pipeline Review, H2 2017" report has been added to Research and Markets' offering.

PTIE : 7.79 (unch)
Pain Therapeutics Reports Positive Regulatory Meeting for REMOXY(TM)

Pain Therapeutics, Inc. (Nasdaq:PTIE), a biopharmaceutical company, today announced that it has successfully concluded a regulatory meeting with the U.S. Food and Drug Administration (FDA) regarding REMOXY,...

PTIE : 7.79 (unch)
Pain Therapeutics Announces New Publication on Alzheimer's Disease

Pain Therapeutics, Inc. (Nasdaq:PTIE), a biopharmaceutical company, today announced a new publication for PTI-125, a clinical-stage drug candidate with a novel mechanism of action for the treatment of...

PTIE : 7.79 (unch)
Pain Therapeutics Companies, Drugs, and Market Projections to 2026

The "Pain Therapeutics - Drugs, Markets and Companies" report from Jain PharmaBiotech has been added to Research and Markets' offering.

PTIE : 7.79 (unch)
U.S. Department of Defense Awards Grant to SiteOne Therapeutics, Supporting Research and Development of Selective Small Molecule NaV1.7 Inhibitors as Acute and Chronic Pain Therapeutics

The U.S. Dept. of Defense is supporting SiteOne Therapeutics in the effort to develop the company's proprietary, highly selective small molecule Naáu¥1.7 inhibitors for the treatment of acute and chronic...

PTIE : 7.79 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Pain Therapeutics is developing a new generation of opioid painkillers.Opioids are drugs derived from the poppy plant. The company uses technology to reformulate opioid drugs, such as morphine, into new painkillers with improved clinical benefits. The company has four opioid painkillers in Phase II clinical...

See More

Key Turning Points

2nd Resistance Point 8.32
1st Resistance Point 8.06
Last Price 7.79
1st Support Level 7.62
2nd Support Level 7.44

See More

52-Week High 12.80
Fibonacci 61.8% 9.09
Fibonacci 50% 7.95
Last Price 7.79
Fibonacci 38.2% 6.81
52-Week Low 3.10

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.